MOTS-C is a mitochondrial-derived peptide that has emerged as a significant subject in metabolic and cellular energy research. Here's what the current literature reveals about this unique signaling molecule.
Part of the PeptidesATX Research Hub
MOTS-C (Mitochondrial Open Reading Frame of the Twelve S rRNA Type-C) is a 16-amino acid peptide encoded within the mitochondrial genome. Unlike the vast majority of peptides used in research, which are encoded by nuclear DNA, MOTS-C belongs to a relatively recently discovered class of molecules known as mitochondrial-derived peptides (MDPs).
The peptide was first identified and characterized in 2015 by researchers at the University of Southern California, who discovered that the mitochondrial 12S rRNA gene contains small open reading frames capable of encoding functional peptides. MOTS-C was the first such peptide identified from this region, and its discovery fundamentally changed how scientists view mitochondrial genetics — demonstrating that mitochondrial DNA does more than simply encode components of the electron transport chain.
Structurally, MOTS-C consists of 16 amino acids with the sequence MRWQEMGYIFYPRKLR. It is produced endogenously and has been detected in various tissues and in circulation, suggesting it functions as a signaling molecule that can act both locally within cells and systemically throughout the body. Its small size, stability, and apparent signaling capacity have made it an attractive subject for peptide research.
In laboratory settings, synthetic MOTS-C is supplied as a lyophilized powder and reconstituted for use in cell culture experiments, in vitro assays, and preclinical animal models. Research-grade MOTS-C is typically supplied at ≥98% purity as verified by HPLC analysis and mass spectrometry confirmation.
To understand why MOTS-C research is significant, it helps to appreciate the central role mitochondria play in cellular biology. Mitochondria are often described as the powerhouses of the cell, responsible for producing adenosine triphosphate (ATP) through oxidative phosphorylation. However, modern research has revealed that mitochondria serve far more complex roles than simple energy production.
Mitochondria are involved in calcium signaling, apoptosis regulation, reactive oxygen species (ROS) production and management, and metabolic sensing. They contain their own circular genome — mitochondrial DNA (mtDNA) — which encodes 13 proteins essential for the electron transport chain, along with the ribosomal RNAs and transfer RNAs needed to translate those proteins.
The discovery of mitochondrial-derived peptides, including MOTS-C and humanin, revealed an additional layer of mitochondrial function: these organelles actively produce signaling peptides that influence cellular metabolism, stress responses, and inter-cellular communication. This concept, sometimes called "mitochondrial-nuclear crosstalk" or retrograde signaling, suggests that mitochondria are not passive energy generators but active participants in cellular decision-making.
MOTS-C appears to be a key player in this communication network. Research has shown that the peptide can translocate to the cell nucleus under conditions of metabolic stress, where it interacts with nuclear DNA to regulate gene expression. This is a remarkable finding — a peptide encoded by mitochondrial DNA that physically moves to the nucleus to influence transcription of nuclear genes. This retrograde signaling pathway represents a direct line of communication between the mitochondrial and nuclear genomes.
The implications for cellular energy regulation are significant. When cells experience metabolic stress — such as glucose deprivation, oxidative stress, or energy depletion — MOTS-C appears to activate protective and adaptive responses. This positions the peptide as a potential mediator of cellular metabolic adaptation, a process that is central to numerous areas of biological research.
Research into MOTS-C has expanded considerably since its initial discovery. Several key areas of investigation have emerged, each exploring different aspects of the peptide's signaling capacity and biological effects.
One of the most well-characterized effects of MOTS-C in research settings is its activation of the AMPK (AMP-activated protein kinase) signaling pathway. AMPK is a master regulator of cellular energy homeostasis, and its activation triggers a cascade of metabolic adjustments including increased glucose uptake, enhanced fatty acid oxidation, and suppression of energy-consuming biosynthetic processes.
Studies have demonstrated that MOTS-C treatment in cell culture models leads to AMPK phosphorylation and downstream activation of metabolic pathways associated with improved cellular energy balance. This AMPK-mediated signaling is thought to be a primary mechanism through which MOTS-C exerts its metabolic effects.
Multiple research groups have investigated the relationship between MOTS-C and glucose metabolism. In preclinical models, MOTS-C administration has been associated with changes in glucose uptake and utilization. The peptide appears to influence glucose metabolism through both AMPK-dependent and AMPK-independent mechanisms, suggesting a complex and multi-layered interaction with metabolic pathways.
This area of research is particularly active because glucose metabolism is central to numerous physiological processes and is dysregulated in many metabolic conditions studied in laboratory settings.
One of the more intriguing findings in MOTS-C research is the observation that the peptide activates some of the same metabolic pathways that are typically activated by physical exercise. Endogenous MOTS-C levels have been shown to increase in response to exercise in both animal models and human studies, and exogenous MOTS-C administration has been reported to activate metabolic pathways that overlap with those induced by physical activity.
This exercise-mimetic quality has generated significant research interest, particularly in the context of understanding how mitochondrial signaling contributes to the metabolic benefits of physical activity.
Research has shown that endogenous MOTS-C levels decline with age in multiple tissues, paralleling the well-documented decline in mitochondrial function that occurs during aging. This correlation has prompted investigation into whether MOTS-C plays a role in age-related changes in metabolic function and whether its decline contributes to metabolic deterioration.
Studies examining MOTS-C in the context of aging-related metabolic research have focused on its effects on mitochondrial function, cellular stress resistance, and metabolic homeostasis in aged cell and animal models.
MOTS-C research has also explored the peptide's role in cellular stress responses. Under conditions of metabolic stress, MOTS-C has been shown to translocate to the cell nucleus where it regulates the expression of genes involved in antioxidant defense and metabolic adaptation. This nuclear translocation under stress conditions suggests that MOTS-C functions as a stress-responsive signaling molecule, activating protective transcriptional programs when cells face metabolic challenges.
The research interest in MOTS-C stems from several factors that make it a uniquely compelling subject for laboratory investigation.
Novel origin. MOTS-C is one of only a handful of known functional peptides encoded by mitochondrial DNA. This makes it intrinsically interesting from a genetic and evolutionary perspective. Understanding how mitochondrial-encoded peptides function expands our fundamental knowledge of mitochondrial biology and inter-genomic communication.
Multi-pathway signaling. Unlike many peptides that act through a single receptor or pathway, MOTS-C appears to influence multiple metabolic pathways simultaneously, including AMPK signaling, glucose metabolism, and nuclear gene expression. This multi-target activity makes it a valuable research tool for studying the interconnections between different metabolic systems.
Endogenous regulation. Because MOTS-C is naturally produced in the body and its levels change in response to physiological conditions (exercise, aging, metabolic stress), it provides a window into how mitochondria communicate metabolic status to the rest of the cell and organism. This endogenous regulation makes it relevant to a wide range of research questions about metabolic homeostasis.
Translational potential. The metabolic pathways influenced by MOTS-C — particularly AMPK activation and glucose metabolism — are central to numerous conditions studied in preclinical research. This positions MOTS-C as a subject with potential translational relevance, driving continued research investment.
Expanding the MDP field. Research on MOTS-C has catalyzed broader interest in mitochondrial-derived peptides as a class. The methods and frameworks developed for MOTS-C research are being applied to other MDPs, creating an expanding field of mitochondrial peptide biology.
Researchers working with MOTS-C should consider several practical factors to ensure the quality and reproducibility of their experimental results.
As with any research peptide, the purity of MOTS-C is critical for reliable experimental outcomes. Research-grade MOTS-C should be accompanied by a Certificate of Analysis (COA) documenting purity by HPLC (≥98%) and identity confirmation by mass spectrometry. Impurities or degradation products can introduce confounding variables into experiments, making sourcing from reputable suppliers essential.
Lyophilized MOTS-C should be stored at -20°C or below to maintain stability. Once reconstituted, the peptide should be aliquoted to avoid repeated freeze-thaw cycles, which can degrade the compound. Reconstitution is typically performed with sterile water or bacteriostatic water, depending on the experimental protocol and timeframe.
When sourcing MOTS-C for research, laboratories should verify that the supplier provides batch-specific COAs with third-party analytical testing, uses proper lyophilization techniques, maintains appropriate storage conditions during shipping, and labels all products for research use only. Suppliers that make therapeutic or medical claims about MOTS-C should be avoided, as this indicates non-compliance with regulatory standards for research compounds.
MOTS-C is a 16-amino acid peptide encoded within the mitochondrial genome (12S rRNA gene). It is classified as a mitochondrial-derived peptide (MDP) and has been studied in research settings for its role in metabolic signaling, AMPK pathway activation, and cellular energy homeostasis.
Researchers study MOTS-C because it represents a novel class of signaling molecules — peptides encoded by mitochondrial DNA rather than nuclear DNA. Its involvement in AMPK signaling, glucose metabolism, and exercise-mimetic pathways makes it a compelling subject for metabolic and aging research.
MOTS-C is used in laboratory research to study mitochondrial-nuclear communication, metabolic signaling pathways, AMPK activation, and cellular energy regulation. It is administered in controlled experimental settings to examine its effects on metabolic markers and cellular function.
Key factors include third-party HPLC purity testing (≥98%), batch-specific Certificates of Analysis, proper lyophilization and storage, research-use-only labeling, and transparent sourcing. Avoid suppliers that make therapeutic claims about MOTS-C.
PeptidesATX offers MOTS-C 10mg with third-party purity testing, batch-specific COA, and same-day shipping from Austin, TX.
View MOTS-C 10mg Browse All PeptidesDisclaimer: This compound is intended for laboratory research use only. It is not approved for human or veterinary use.